| CAS NO: | 197723-00-5 |
| 规格: | 98% |
| 分子量: | 502.14 |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Background:
NKP-1339(IT-139) is a ruthenium(iii) coordination anticancer compound based on target to transferrin.
参考文献:
[1]. Kuhn PS, et al. Improved reaction conditions for the synthesis of new NKP-1339 derivatives and preliminary investigations on their anticancer potential. Dalton Trans. 2014 Nov 11.
[2]. Robert Trondl, et al. ChemInform Abstract: NKP-1339, the First Ruthenium-Based Anticancer Drug on the Edge to Clinical Application.
m.cnreagent.com